Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

118.73
Delayed Data
As of Apr 28
 +0.30 / +0.25%
Today’s Change
74.05
Today|||52-Week Range
137.88
+6.25%
Year-to-Date
No recent news for GW Pharmaceuticals PLC.

Today’s Trading

Previous close118.43
Today’s open118.69
Day’s range118.24 - 119.49
Volume116,341
Average volume (3 months)321,621
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-19.04%
Earnings growth (this year)-40.61%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-66.86%
P/E ratio--
Price/Sales205.08
Price/Book5.76

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...-0.48-0.83%
ICPTIntercept Pharmaceut...-0.88-0.78%
VRXValeant Pharmaceutic...-0.13-1.39%
CBPOChina Biologic Produ...-0.22-0.19%
Data as of 4:01pm ET, 04/28/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$1.35
Annual revenue (last year)$14.6M
Annual profit (last year)-$90.0M
Net profit margin-617.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts